Preferred Name |
Levamisole |
|
Synonyms |
|
|
Definitions |
An anthelmintic drug. Co-administered with fluorouracil in the treatment of Dukes' stage C colon cancer, levamisole restores immune function through stimulating antibody formation, enhancing T-cell activity, and potentiating macrophage function. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C61609 |
|
ALT_DEFINITION |
An antiparasitic drug that is also being studied in cancer therapy with fluorouracil. |
|
CAS_Registry |
14769-73-4 |
|
Chemical_Formula |
C11H12N2S |
|
code |
C61609 |
|
Contributing_Source |
FDA |
|
definition |
An anthelmintic drug. Co-administered with fluorouracil in the treatment of Dukes' stage C colon cancer, levamisole restores immune function through stimulating antibody formation, enhancing T-cell activity, and potentiating macrophage function. (NCI04) |
|
FDA_UNII_Code |
2880D3468G |
|
Has_Salt_Form | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
label |
Levamisole |
|
Legacy Concept Name |
Levamisole_Base |
|
Preferred_Name |
Levamisole |
|
prefixIRI |
NCIT:C61609 |
|
prefLabel |
Levamisole |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0023556 |
|
subClassOf |